Immunohistochemistry of a skin biopsy revealed a dense infiltrate of mononuclear cells positive for CD4, CD56, and CD123 consistent with a diagnosis of BPDCN. The gene discussed is NCAM1; the disease is CD4+/CD56+ hematodermic neoplasm.